Mikhail Blagosklonny holds degrees as both an MD and a Ph.D. He works at the Cancer Institute in Buffalo, New York as a professor in the field of Oncology. He has numerous interests including cellular and molecular biology as well as in the field of oncology. His work has made improvements in the cycling of cells in regards to cancer and aging and led to the developing of drugs used to help in the fight against cancer. He has written theories regarding the process of aging and the best way to approach cancer.
Three-hundred articles on research have been published by Dr. Blagosklonny including reviews and chapters from books. Mikhail Blagosklonny is the Editor of Cell Cycle and he founded Aging. He has been an Associate Editor for numerous, prestigious publications and his experience and knowledge in the field of Oncology are well respected.
Dr. Blagosklonny studied internal medicine, which is partially how his degrees were earned. Experimental medicine is what he studied for his Ph.D. Originally, he held the position of associate professor in New York, but later went to work as a scientist, also in New York. It was not until 2009 that he was hired for the position of Oncology Professor at The Roswell Park Cancer Institute.
Mikhail Blagosklonny’s extensive research specializes in therapies targeted at cancer and will protect the normal cells inside of the body from being damaged. He has also researched again and applicable drugs, leading to the discovery of Rapamycin. This drug was developed for the treatment of cancer but has benefits in treating the extension of life.
Dr. Mikhail Blagosklonny is also the editor of Oncotarget. This is an open journal for medicine that is reviewed by it’s peers every week. All aspects of Oncology are researched in this journal. Oncotarget was founded in 2010 and Impact Journals is responsible for it’s publication.